title: Price of bevacizumab for intravitreal injection in New Zealand.
authors.forename: Poorna
authors.initials: P
authors.lastname: Abeysiri
authors.forename: Nicholas R
authors.initials: NR
authors.lastname: Johnston
authors.forename: Anthony C B
authors.initials: AC
authors.lastname: Molteno
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000191:economics*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000191:economics*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D017046:Cost Savings / Q000379:methods; D003365:Costs and Cost Analysis; D016527:Drug Costs; D006801:Humans; D007267:Injections; D009520:New Zealand; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014822:Vitreous Body
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab